Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to Be Used as A Platform for Ipsc‐Hepatocyte Culture

Author:

Acun Aylin123,Fan Letao12,Oganesyan Ruben12,Uygun Korkut M.12,Yeh Heidi2,Yarmush Martin L.124,Uygun Basak E.12ORCID

Affiliation:

1. Center for Engineering in Medicine and Surgery Massachusetts General Hospital Harvard Medical School Boston MA 02114 USA

2. Shriners Children's Boston, Boston MA 02114 USA

3. Department of Biomedical Engineering Widener University Chester PA 19013 USA

4. Department of Biomedical Engineering Rutgers University Piscataway NJ 08854 USA

Abstract

AbstractDecellularization of discarded whole livers and their recellularization with patient‐specific induced pluripotent stem cells (iPSCs) to develop a functional organ is a promising approach to increase donor pool. The effect of extracellular matrix (ECM) of marginal livers on iPSC‐hepatocyte differentiation and function has not been shown. To test the effect of donor liver ECM age and steatosis, we decellularized young, old, as well as no, low and high steatosis livers. All livers were decellularized successfully. High steatosis livers had fat remaining on the ECM after decellularization. Old donor liver ECM induced lower marker expression in early differentiation stages, compared to young liver ECM, while this difference was closed at later stages and did not affect iPSC‐hepatocyte function significantly. High steatosis levels of liver ECM led to higher albumin mRNA expression and secretion while at later stages of differentiation expression of major CYP450 enzymes was highest in low steatosis liver ECM. Both primary human hepatocytes and iPSC‐hepatocytes showed an increase in fat metabolism marker expression with increasing steatosis levels most likely induced by excess fat remaining on the ECM. Overall, removal of excess fat from liver ECM may be needed for inducing proper hepatic function after recellularization.This article is protected by copyright. All rights reserved

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3